Key result
Continuous-flow LVAD improves functional status from NYHA class III-IV to class II in advanced heart failure.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Left ventricular assist device (LVAD) is a good treatment option for the patients ineligible for cardiac transplantation. Several studies have demonstrated that a ventricular assist device improves the quality of life and prognosis of the patients with end-stage heart failure. A 75-yr-old man debilitated with New York Heart Association (NYHA) functional class III-IV due to severe left ventricular systolic dysfunction received LVAD implantation as a destination therapy. The patient was discharged with improved functional status (NYHA functional class II) after appropriate cardiac rehabilitation and education about how to manage the device and potential emergency situations. This is the first case of successful continuous-flow LVAD implantation as a destination therapy in Korea.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2014) conducted a case report in Severe left ventricular systolic dysfunction / End-stage heart failure (n=1). Continuous-flow left ventricular assist device (LVAD) implantation as destination therapy was evaluated on Functional status (NYHA functional class) at discharge. Continuous-flow LVAD implantation as destination therapy improved functional status from NYHA class III-IV to class II at discharge in a 75-year-old man with severe LV systolic dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: